Table 5 Use of serum free ß-subunit (hCGß plus hyperglycosylated hCGß) and urine ß-core fragment as tumor markers for detection of malignancies
Malignancy | hCGß as a tumor marker | ß-core fragment as a tumor marker | ||
|---|---|---|---|---|
|  | Number of Cases | Serum hCGß (> 3 pmol/L) | Number of Cases | Urine ß-core fragment (> 3 pmol/L) |
Bladder cancer | 170 | 35% | 102 | 48% |
Cervical cancer | 60 | 37% | 410 | 48% |
Colorectal cancer | 436 | 17% | Â | Â |
Endometrial cancer | 55 | 33% | 157 | 47% |
Lung cancer | 243 | 18% | 122 | 45% |
Ovarian cancer | 150 | 38% | 207 | 66% |
Pancreatic cancer | Â | Â | 29 | 55% |
Vulvar | 64 | 41% | Â | Â |
TOTAL | 1164 | Mean 30% | 1027 | Mean 48% |